SEC 13F Intelligence

Bardin Hill Management Partners LP / FPRX

Bardin Hill Management Partners LP’s Five Prime Therapeutics Inc Position

Does Bardin Hill Management Partners LP own Five Prime Therapeutics Inc (FPRX)? Not currently — the last reported position was 209.0K shares worth $8M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q1 2021
Shares
209.0K
% of Portfolio
+1.46%
Quarters Held
1
position exited

Position History FPRX

Reported value by quarter
Q1 ’21: $8MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2021209.0K$8M+1.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bardin Hill Management Partners LP’s full portfolio or all institutional holders of FPRX.